A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bladder Cancer
- Head/Neck Cancers
- Lung Cancer
- Melanoma Cancer
- Metastatic Cancer
- Renal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: This is an open label Phase 2 screening trial in subjects.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03693014
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yoshiya Yamada, MD Memorial Sloan Kettering Cancer Center